These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38433676)

  • 1.
    Ramachandran R
    J Law Med Ethics; 2023; 51(S2):41-45. PubMed ID: 38433676
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Sarpatwari A
    J Law Med Ethics; 2023; 51(S2):28-34. PubMed ID: 38433672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US public investment in development of mRNA covid-19 vaccines: retrospective cohort study.
    Lalani HS; Nagar S; Sarpatwari A; Barenie RE; Avorn J; Rome BN; Kesselheim AS
    BMJ; 2023 Mar; 380():e073747. PubMed ID: 36858453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NIH-led research response to COVID-19.
    Collins F; Adam S; Colvis C; Desrosiers E; Draghia-Akli R; Fauci A; Freire M; Gibbons G; Hall M; Hughes E; Jansen K; Kurilla M; Lane HC; Lowy D; Marks P; Menetski J; Pao W; Pérez-Stable E; Purcell L; Read S; Rutter J; Santos M; Schwetz T; Shuren J; Stenzel T; Stoffels P; Tabak L; Tountas K; Tromberg B; Wholley D; Woodcock J; Young J
    Science; 2023 Feb; 379(6631):441-444. PubMed ID: 36730407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Profiles of SARS-CoV-2 Spike-Specific Human Milk Antibodies Elicited by mRNA- and Adenovirus-Based COVID-19 Vaccines.
    Yang X; Fox A; DeCarlo C; Norris C; Griffin S; Wedekind S; Flanagan JM; Shenker N; Powell RL
    Breastfeed Med; 2022 Aug; 17(8):638-646. PubMed ID: 35675683
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of Communication Strategies for Mitigating COVID-19 Vaccine-Specific Hesitancy in Canada.
    Merkley E; Loewen PJ
    JAMA Netw Open; 2021 Sep; 4(9):e2126635. PubMed ID: 34591105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute dizziness and mental alteration associated with Moderna COVID-19 vaccine: a case report.
    Pinzon RT; Haryono FK; Darmawan NE; Salikim MAM; Veronica V
    BMC Neurol; 2022 Aug; 22(1):322. PubMed ID: 36028809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exceptional Prices of Medical and Other Supplies during the COVID-19 Pandemic in Ecuador.
    Ortiz-Prado E; Fernandez-Naranjo R; Torres-Berru Y; Lowe R; Torres I
    Am J Trop Med Hyg; 2021 May; 105(1):81-87. PubMed ID: 34014837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.
    Oliver SE; Gargano JW; Marin M; Wallace M; Curran KG; Chamberland M; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1653-1656. PubMed ID: 33382675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models.
    Alonso Ruiz A; Bezruki A; Shinabargar E; Large K; Vieira M; Slovenski I; Liu Y; Agarwal S; Becker A; Moon S
    Global Health; 2024 Mar; 20(1):25. PubMed ID: 38532484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerating clinical trial development in vaccinology: COVID-19 and beyond.
    Corey L; Miner MD
    Curr Opin Immunol; 2022 Jun; 76():102206. PubMed ID: 35569415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
    Fleming-Dutra KE; Wallace M; Moulia DL; Twentyman E; Roper LE; Hall E; Link-Gelles R; Godfrey M; Woodworth KR; Anderson TC; Rubis AB; Shanley E; Jones JM; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley M; Meyer S; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(26):859-868. PubMed ID: 35771731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine safety in Australia during the COVID-19 pandemic: Lessons learned on the frontline.
    Laemmle-Ruff I; Lewis G; Clothier HJ; Dimaguila GL; Wolthuizen M; Buttery J; Crawford NW
    Front Public Health; 2022; 10():1053637. PubMed ID: 36408022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic and minority group differences in engagement with COVID-19 vaccination programmes - at Pandemic Pace; when vaccine confidence in mass rollout meets local vaccine hesitancy.
    Reid JA; Mabhala MA
    Isr J Health Policy Res; 2021 May; 10(1):33. PubMed ID: 34044891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines-Early experience with vaccine rollout in a multi-site healthcare system.
    Al-Obaydi S; Hennrikus E; Mohammad N; Lehman EB; Thakur A; Al-Shaikhly T
    PLoS One; 2022; 17(8):e0272691. PubMed ID: 35930586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving pandemic preparedness through better, faster influenza vaccines.
    Newland M; Durham D; Asher J; Treanor JJ; Seals J; Donis RO; Johnson RA
    Expert Rev Vaccines; 2021 Mar; 20(3):235-242. PubMed ID: 33576708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.